Oncolines’ HTS service is designed for virtual pharma and small to mid-size biotech companies that have a validated target but no chemical starting point, or that want access to novel, proprietary compound chemistry. It is particularly well-suited for programs targeting enzymes, GPCRs, kinases, or protein–protein interactions, among other target classes. If you are unsure whether your program is a fit, contact us for a no-commitment scientific consultation. The assay development team can discuss suitability for your specific target during an initial consultation.
